Use of CA 125 to monitor patients with ovarian epithelial carcinomas
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 33 (2) , 193-197
- https://doi.org/10.1016/0090-8258(89)90550-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- CA 125 FOR THE MONITORING OF OVARIAN-CARCINOMA DURING PRIMARY THERAPY1987
- The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1986
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- PREOPERATIVE EVALUATION OF SERUM CA-125 LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN-CANCER1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958